-
1
-
-
2342510068
-
Chronic disorders of calcium and phosphate metabolism in children
-
COI: 1:CAS:528:DyaG38XhsFansQ%3D%3D, PID: 14876389
-
Fanconi G (1951) Chronic disorders of calcium and phosphate metabolism in children. Schweiz Med Wochenschr 81:908–913
-
(1951)
Schweiz Med Wochenschr
, vol.81
, pp. 908-913
-
-
Fanconi, G.1
-
2
-
-
49749212730
-
Idiopathic hypercalcaemia in infants
-
Lightwood R, Stapleton T (1953) Idiopathic hypercalcaemia in infants. Lancet 262:255–256
-
(1953)
Lancet
, vol.262
, pp. 255-256
-
-
Lightwood, R.1
Stapleton, T.2
-
3
-
-
79961102329
-
Mutations in CYP24A1 and idiopathic infantile hypercalcemia
-
COI: 1:CAS:528:DC%2BC3MXpvFSiu70%3D, PID: 21675912
-
Schlingmann KP, Kaufmann M, Weber S, Irwin A, Goos C, John U, Misselwitz J, Klaus G, Kuwertz-Bröking E, Fehrenbach H, Wingen AM, Güran T, Hoenderop JG, Bindels RJ, Prosser DE, Jones G, Konrad M (2011) Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N Engl J Med 365:410–421
-
(2011)
N Engl J Med
, vol.365
, pp. 410-421
-
-
Schlingmann, K.P.1
Kaufmann, M.2
Weber, S.3
Irwin, A.4
Goos, C.5
John, U.6
Misselwitz, J.7
Klaus, G.8
Kuwertz-Bröking, E.9
Fehrenbach, H.10
Wingen, A.M.11
Güran, T.12
Hoenderop, J.G.13
Bindels, R.J.14
Prosser, D.E.15
Jones, G.16
Konrad, M.17
-
4
-
-
84856778061
-
Genetic defect in CYP24A1, the vitamin D 24-hydroxylase gene, in a patient with severe infantile hypercalcemia
-
COI: 1:CAS:528:DC%2BC38XisFOns7s%3D, PID: 22112808
-
Dauber A, Nguyen TT, Sochett E, Cole DE, Horst R, Abrams SA, Carpenter TO, Hirschhorn JN (2012) Genetic defect in CYP24A1, the vitamin D 24-hydroxylase gene, in a patient with severe infantile hypercalcemia. J Clin Endocrinol Metab 97:E268–E274
-
(2012)
J Clin Endocrinol Metab
, vol.97
, pp. E268-E274
-
-
Dauber, A.1
Nguyen, T.T.2
Sochett, E.3
Cole, D.E.4
Horst, R.5
Abrams, S.A.6
Carpenter, T.O.7
Hirschhorn, J.N.8
-
5
-
-
80455162447
-
CYP24A1 mutations in idiopathic infantile hypercalcemia
-
COI: 1:CAS:528:DC%2BC3MXhsVWqurzI, PID: 22047572, author reply 1742–1743
-
Streeten EA, Zarbalian K, Damcott CM (2011) CYP24A1 mutations in idiopathic infantile hypercalcemia. N Engl J Med 365:1741–1742, author reply 1742–1743
-
(2011)
N Engl J Med
, vol.365
, pp. 1741-1742
-
-
Streeten, E.A.1
Zarbalian, K.2
Damcott, C.M.3
-
6
-
-
84880045700
-
Loss-of-function mutations of CYP24A1, the vitamin D 24-hydroxylase gene, cause long-standing hypercalciuric nephrolithiasis and nephrocalcinosis
-
COI: 1:CAS:528:DC%2BC3sXpvVynu7c%3D, PID: 23470222
-
Dinour D, Beckerman P, Ganon L, Tordjman K, Eisenstein Z, Holtzman EJ (2013) Loss-of-function mutations of CYP24A1, the vitamin D 24-hydroxylase gene, cause long-standing hypercalciuric nephrolithiasis and nephrocalcinosis. J Urol 190:552–557
-
(2013)
J Urol
, vol.190
, pp. 552-557
-
-
Dinour, D.1
Beckerman, P.2
Ganon, L.3
Tordjman, K.4
Eisenstein, Z.5
Holtzman, E.J.6
-
7
-
-
84863229578
-
Hypercalcemia, hypercalciuria, and elevated calcitriol concentrations with autosomal dominant transmission due to CYP24A1 mutations: effects of ketoconazole therapy
-
COI: 1:CAS:528:DC%2BC38Xkt1ymt7w%3D, PID: 22337913
-
Tebben PJ, Milliner DS, Horst RL, Harris PC, Singh RJ, Wu Y, Foreman JW, Chelminski PR, Kumar R (2012) Hypercalcemia, hypercalciuria, and elevated calcitriol concentrations with autosomal dominant transmission due to CYP24A1 mutations: effects of ketoconazole therapy. J Clin Endocrinol Metab 97:E423–E427
-
(2012)
J Clin Endocrinol Metab
, vol.97
, pp. E423-E427
-
-
Tebben, P.J.1
Milliner, D.S.2
Horst, R.L.3
Harris, P.C.4
Singh, R.J.5
Wu, Y.6
Foreman, J.W.7
Chelminski, P.R.8
Kumar, R.9
-
8
-
-
82855166085
-
Calcium and bone metabolism disorders during pregnancy and lactation
-
COI: 1:CAS:528:DC%2BC3MXhsFSjtLnL, PID: 22108281
-
Kovacs CS (2011) Calcium and bone metabolism disorders during pregnancy and lactation. Endocrinol Metab Clin North Am 40:795–826
-
(2011)
Endocrinol Metab Clin North Am
, vol.40
, pp. 795-826
-
-
Kovacs, C.S.1
-
9
-
-
79958810315
-
CYP24A1 and kidney disease
-
COI: 1:CAS:528:DC%2BC3MXntF2ns7s%3D, PID: 21610497
-
Petkovich M, Jones G (2011) CYP24A1 and kidney disease. Curr Opin Nephrol Hypertens 20:337–344
-
(2011)
Curr Opin Nephrol Hypertens
, vol.20
, pp. 337-344
-
-
Petkovich, M.1
Jones, G.2
-
10
-
-
12344280997
-
Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse
-
COI: 1:CAS:528:DC%2BD2MXotlWgtQ%3D%3D, PID: 15498883
-
Masuda S, Byford V, Arabian A, Sakai Y, Demay MB, St-Arnaud R, Jones G (2005) Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse. Endocrinology 146:825–834
-
(2005)
Endocrinology
, vol.146
, pp. 825-834
-
-
Masuda, S.1
Byford, V.2
Arabian, A.3
Sakai, Y.4
Demay, M.B.5
St-Arnaud, R.6
Jones, G.7
-
11
-
-
0003331543
-
Deficient mineralization of intramembranous bone in vitamin D-24-hydroxylase-ablated mice is due to elevated 1,25-dihydroxyvitamin D and not to the absence of 24,25-dihydroxyvitamin D
-
COI: 1:CAS:528:DC%2BD3cXlt1Wmu7w%3D, PID: 10875271
-
St-Arnaud R, Arabian A, Travers R, Barletta F, Raval-Pandya M, Chapin K, Depovere J, Mathieu C, Christakos S, Demay MB, Glorieux FH (2000) Deficient mineralization of intramembranous bone in vitamin D-24-hydroxylase-ablated mice is due to elevated 1,25-dihydroxyvitamin D and not to the absence of 24,25-dihydroxyvitamin D. Endocrinology 141:2658–2666
-
(2000)
Endocrinology
, vol.141
, pp. 2658-2666
-
-
St-Arnaud, R.1
Arabian, A.2
Travers, R.3
Barletta, F.4
Raval-Pandya, M.5
Chapin, K.6
Depovere, J.7
Mathieu, C.8
Christakos, S.9
Demay, M.B.10
Glorieux, F.H.11
-
12
-
-
79961228421
-
Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness
-
COI: 1:CAS:528:DC%2BC3MXht1yitLnL, PID: 21706518
-
Hollis BW, Johnson D, Hulsey TC, Ebeling M, Wagner CL (2011) Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness. J Bone Miner Res 26:2341–2357
-
(2011)
J Bone Miner Res
, vol.26
, pp. 2341-2357
-
-
Hollis, B.W.1
Johnson, D.2
Hulsey, T.C.3
Ebeling, M.4
Wagner, C.L.5
-
13
-
-
84872868674
-
Vitamin D—effects on skeletal and extraskeletal health and the need for supplementation
-
COI: 1:CAS:528:DC%2BC3sXhs1yrt7g%3D, PID: 23306192
-
Wacker M, Holick MF (2013) Vitamin D—effects on skeletal and extraskeletal health and the need for supplementation. Nutrients 5:111–148
-
(2013)
Nutrients
, vol.5
, pp. 111-148
-
-
Wacker, M.1
Holick, M.F.2
-
14
-
-
84872864817
-
A randomized trial of vitamin D supplementation in 2 community health center networks in South Carolina
-
Wagner CL, McNeil R, Hamilton SA, Winkler J, Rodriguez Cook C, Warner G, Bivens B, Davis DJ, Smith PG, Murphy M, Shary JR, Hollis BW (2013) A randomized trial of vitamin D supplementation in 2 community health center networks in South Carolina. Am J Obstet Gynecol 208(137):e131–113
-
(2013)
Am J Obstet Gynecol
, vol.208
, Issue.137
, pp. e113-e131
-
-
Wagner, C.L.1
McNeil, R.2
Hamilton, S.A.3
Winkler, J.4
Rodriguez Cook, C.5
Warner, G.6
Bivens, B.7
Davis, D.J.8
Smith, P.G.9
Murphy, M.10
Shary, J.R.11
Hollis, B.W.12
-
15
-
-
0036307924
-
Primary hyperparathyroidism in pregnancy: evidence-based management
-
PID: 12140371
-
Schnatz PF, Curry SL (2002) Primary hyperparathyroidism in pregnancy: evidence-based management. Obstet Gynecol Surv 57:365–376
-
(2002)
Obstet Gynecol Surv
, vol.57
, pp. 365-376
-
-
Schnatz, P.F.1
Curry, S.L.2
-
16
-
-
52949119588
-
Maternal hypercalcemia as a possible cause of unexplained fetal polyhydramnion: a case series
-
Shani H, Sivan E, Cassif E, Simchen MJ (2008) Maternal hypercalcemia as a possible cause of unexplained fetal polyhydramnion: a case series. Am J Obstet Gynecol 199(410):e411–e415
-
(2008)
Am J Obstet Gynecol
, vol.199
, Issue.410
, pp. e411-e415
-
-
Shani, H.1
Sivan, E.2
Cassif, E.3
Simchen, M.J.4
-
17
-
-
0025305635
-
Parathyroid hormone-related protein and hypercalcemia secondary to massive mammary hyperplasia
-
COI: 1:STN:280:DyaK3c3gs1Sisw%3D%3D, PID: 2320085
-
Khosla S, van Heerden JA, Gharib H, Jackson IT, Danks J, Hayman JA, Martin TJ (1990) Parathyroid hormone-related protein and hypercalcemia secondary to massive mammary hyperplasia. N Engl J Med 322:1157
-
(1990)
N Engl J Med
, vol.322
, pp. 1157
-
-
Khosla, S.1
van Heerden, J.A.2
Gharib, H.3
Jackson, I.T.4
Danks, J.5
Hayman, J.A.6
Martin, T.J.7
-
19
-
-
16544375383
-
Milk-alkali syndrome in pregnancy
-
PID: 15516453
-
Picolos MK, Sims CR, Mastrobattista JM, Carroll MA, Lavis VR (2004) Milk-alkali syndrome in pregnancy. Obstet Gynecol 104:1201–1204
-
(2004)
Obstet Gynecol
, vol.104
, pp. 1201-1204
-
-
Picolos, M.K.1
Sims, C.R.2
Mastrobattista, J.M.3
Carroll, M.A.4
Lavis, V.R.5
-
20
-
-
17144414069
-
Life-threatening milk-alkali syndrome resulting from antacid ingestion during pregnancy
-
PID: 15804228
-
Gordon MV, McMahon LP, Hamblin PS (2005) Life-threatening milk-alkali syndrome resulting from antacid ingestion during pregnancy. Med J Aust 182:350–351
-
(2005)
Med J Aust
, vol.182
, pp. 350-351
-
-
Gordon, M.V.1
McMahon, L.P.2
Hamblin, P.S.3
-
21
-
-
0036047091
-
Milk-alkali syndrome in pregnancy, associated with elevated levels of parathyroid hormone-related protein
-
COI: 1:STN:280:DC%2BD38nit1GntQ%3D%3D, PID: 12380706
-
Morton A (2002) Milk-alkali syndrome in pregnancy, associated with elevated levels of parathyroid hormone-related protein. Intern Med J 32:492–493
-
(2002)
Intern Med J
, vol.32
, pp. 492-493
-
-
Morton, A.1
|